4//SEC Filing
LEE JENNIFER LING 4
Accession 0001127602-19-010841
CIK 0001682852other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:16 PM ET
Size
6.9 KB
Accession
0001127602-19-010841
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
LEE JENNIFER LING
Chief Accounting Officer
Transactions
- Award
Common Stock
2019-03-08+4,780→ 4,780 total - Award
Stock Option (Right to Buy)
2019-03-08+25,097→ 25,097 totalExercise: $20.93From: 2020-03-08Exp: 2029-03-08→ Common Stock (25,097 underlying)
Footnotes (2)
- [F1]25% of the shares subject to this restricted stock unit award will vest on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F2]25% of this option will vest and become exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001675118
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:16 PM ET
- Size
- 6.9 KB